Litcius/Paper detail

In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice

Narayanappa Amruta, Elizabeth B. Engler-Chiurazzi, Isabel C. Murray-Brown, Timothy E. Gressett, Ifechukwude Joachim Biose, Wesley H. Chastain, Jaime B. Befeler, Gregory Bix

2021Life Sciences31 citationsDOIOpen Access PDF

Topics & Concepts

In vivoBiologyImmunologyVirologyIntegrinChemokineLungIn vitroCoronavirusInflammationMedicineReceptorInfectious disease (medical specialty)Coronavirus disease 2019 (COVID-19)PathologyDiseaseInternal medicineBiochemistryBiotechnologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesViral Infections and Outbreaks Research
In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice | Litcius